"Health News - Medicine, Diet and Fitness"

If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!

Classical Homeopathy - natural, holistic, alternative medicine Mental Health - Depression, Anxiety, PTSD, mental illness Learning and behavioral disorders, foster care

Mental Health HEALTH RESOURCES UK MASSAGE LONDON ALTERNATIVE MEDICINE
Aetna Health Care Affordable Health Care Alternative Health Alternative Medicine Animal Health Aromatherapy Canada Health Cancer Health Cat Health Centrum Multivitamin

(more…)

By Meghan Yost
Ivanhoe Health Correspondent

ORLANDO, Fla. (Ivanhoe Newswire) — Good news for men: a new prostate cancer vaccine proven powerful in mice may also prevent the disease in humans.

Researchers at the University of Southern California have created a vaccine that prevented prostate cancer in 90 percent of mice genetically predisposed to developing it. After one year, only two of the 20 mice given the vaccine had developed prostate cancer while all of the mice who did not receive it died.

(Ivanhoe Newswire) — The size of a child’s tumor is less important in determining prognosis for thyroid cancer than the age at which he is diagnosed and treated.

Italian researchers arrived at that conclusion after evaluating about 2,700 children and adults who underwent surgery to treat the condition. Even though children tended to have more aggressive tumors than adults, and younger children had larger tumors, overall kids actually had a better prognosis. The researchers concluded age at diagnosis is the most important factor when determining the outcomes for pediatric thyroid cancer patients.

California bill will prod national decision makers, serve in lieu of federal policy if Congress fails to act

SACRAMENTO—The California Assembly Health Committee passed the Pharmaceutical Drug Information and Safety Act, SB 606 (Scott), today with all members present voting in favor of the bill. The measure will require pharmaceutical companies to disclose the results of clinical studies, meaning that doctors, patients, researchers and even industry competitors will gain access to information on the side effects and effectiveness of medicine currently on the market.

(more…)

California bill will prod national decision makers, serve in lieu of federal policy if Congress fails to act

SACRAMENTO—The California Assembly Health Committee passed the Pharmaceutical Drug Information and Safety Act, SB 606 (Scott), today with all members present voting in favor of the bill. The measure will require pharmaceutical companies to disclose the results of clinical studies, meaning that doctors, patients, researchers and even industry competitors will gain access to information on the side effects and effectiveness of medicine currently on the market.

(more…)

The German chemical and pharmaceutical company Merck KGaA had its profits rise for the final quarter of last year by 34 per cent to 109.5 million euros. The growth was said to be down to increased demand for liquid crystals for computer displays.

For 2005 as a whole, sales rose 9.9 per cent and profits were almost unchanged at 659 million euros. Merck executive board chairman Dr Michael Roemer said: “The year 2005 was very successful for Merck thanks to innovative products and the hard work of our employees. “As we see this level of success continuing, we expect our top and bottom lines for 2006 - excluding exceptional items - will improve by a high single-digit rate. In fact, we see no reason why this development should not continue beyond this year.”
(more…)

Just under 150 Perth women have contributed to major international research at the Telethon Institute for Child Health Research that has proved that the new Cervarix vaccine provides broader protection against cervical cancer.

The results, published today in the prestigious international journal Lancet, show that while the vaccine provides effective protection against high grade cervical pre-cancerous lesions caused by human papillomavirus (HPV) types 16 and 18, it also demonstrated additional protection against infections from other strains of HPV that account for another 10 percent of cervical cancers.

(more…)

A woman suffering from early-stage breast cancer has lost a legal battle to force her health authority to treat her with Herceptin. High court judge Mr Justice Bean ruled this morning that that Swindon primary care trust (PCT) in Wiltshire did not need to pay for Ann Marie Rogers, 54, to be treated with the drug, which can cost up to 20,000 for one year of treatment.

Mr Justice Bean said he was sympathetic to Ms Rogers’ situation but had to base his decision solely on whether or not he felt her PCT’s decision was unlawful. When the judge made his ruling Ms Rogers shook her head and looked downwards. She has been given leave to appeal. Herceptin is said to halve the chance of the aggressive HER-2 form of breast cancer returning, but has not been licensed for use in women with early stage cancer.
(more…)

Researchers at the University of Edinburgh have shown that hormone therapy can extend life in ovarian cancer patients, giving women a new alternative to chemotherapy.

The study, published today in Clinical Cancer Research, has proved for the first time that the targeted use of an anti-oestrogen drug could prolong the life of some patients by up to three years, and delay the use of chemotherapy in others.

Letrozole hormone therapy – already used with great success in the treatment of breast tumours - attacks cancer by turning off its oestrogen supply. But scientists now believe that in those ovarian cancers which are highly sensitive to oestrogen, this blocking mechanism could slow the growth and spread of disease.

(more…)

Researchers at Children’s Hospital Boston report finding a new way to increase stem cells in blood, suggesting a possible treatment to help patients who undergo chemotherapy or bone marrow transplant for leukemia and other cancers recover their immune function more quickly. In the June 21 issue of Nature, they demonstrate that a stable analog of prostaglandin can enhance the blood-forming system, both during embryonic development and after it’s been damaged.

(more…)